Bauer, Karin http://orcid.org/0000-0001-9927-042X
Machherndl-Spandl, Sigrid
Kazianka, Lukas
Sadovnik, Irina
Gültekin, Sinan
Suessner, Susanne
Proell, Johannes
Lauf, Jeroen
Hoermann, Gregor http://orcid.org/0000-0002-7374-4380
Eisenwort, Gregor
Häfner, Norman http://orcid.org/0000-0002-7012-483X
Födermayr-Mayrleitner, Mathilde
Schmolke, Ann-Sofie
van der Kouwe, Emiel
Platzbecker, Uwe http://orcid.org/0000-0003-1863-3239
Lion, Thomas
Weltermann, Ansgar
Zach, Otto
Webersinke, Gerald
Germing, Ulrich
Gabriel, Christian http://orcid.org/0000-0003-2043-9320
Sperr, Wolfgang R.
Béné, Marie C.
Staber, Philipp B. http://orcid.org/0000-0001-6729-7708
Bettelheim, Peter
Valent, Peter http://orcid.org/0000-0003-0456-5095
Funding for this research was provided by:
Austrian Science Fund (F4701-B20, F4704-B20)
Article History
Received: 2 May 2023
Revised: 21 August 2023
Accepted: 23 August 2023
First Online: 6 September 2023
Competing interests
: The authors declare no completing interests in this study. Conflict of interest outside the study are: P.V. received research grants from Celgene, Novartis, Incyte, Pfizer, and AOP Orphan, and honoraria from Celgene, Novartis, Pfizer, Incyte, and AOP Orphan. S.M.S received honoraria from Celgene, Novartis, Pfizer, Abbvie, Amgen, Jazz, Gilead, Servier and Incyte. P.B. was supported by Alexion outside the study. T.L. received research grants from Incyte and Novartis, and honoraria from Incyte, Pfizer, Angelini, Amgen and Chimerix. O.Z. was supported by Pfizer, Takeda, Amgen, Novartis, BMS, Genzyme, Sanofi, Pierre Fabre and Roche, and he is part of advisory boards of Amgen, Pfizer and Novartis. U.G. received research support from Novartis and Celgene, and honoraria from Celgene, Jazz, Novartis and Jansen. G.W. received research grants from Abbvie, Amgen, AstraZeneca, BMS, Böhringer Ingelheim, Gilead, Incyte, Lilly, Mundipharma, Novartis, Pfizer, Roche and Tesaro. G.H. received research grants from Novartis, he received honoraria and he is part of advisory boards of Novartis, Roche, Beckman Coulter, Pfizer, Celgene, Bristol-Myers Squibb. L.K. was supported by a DOCmed Fellowship of the Austrian Academy of Sciences (OeAW) and a research grant of the Vienna Comprehensive Cancer Center (CCC). P.B.S. reports grants and personal fees from Roche, Celgene, and AbbVie; and personal fees from Amgen, Takeda, AbbVie, and Janssen Cilag outside the submitted work.The other authors declare that they have no conflicts of interest.